synergene active ingredients

systematic approach for innovation

Achievements and Future Plans

Synergene Active Ingredients Pvt.Ltd was incorporated in 2006.

Synergene R&D was established in 2007.

ISO 9001: 2008 Certified by AQA International LLC & Accredited by ANAB.

WHO GMP Certified in the Year 2009.

CEP certificate for Fluconazole received in May 2014.(R0-CEP 2011-338 –REV00 dated 27.05.2014).

Written Confirmation received for 5 products in September 2014 for fluconazole, Terbinafine Hcl, Escitalopram Oxalate, Losartan Potassium, Dapoxetine Hcl.

USFDA was inspected our Vishakhapatnam facility and E.I.R Received December 2016.

Business Partner Excellence Award winner for 2016 from Dr.Reddy’s Laboratories Ltd.                   

CEP certificate for Terbinafine Hcl received in March 2017.( RO-CEP 2015-235-Rev 00 Dated 30.03.2017).

Process Patents received for Escitalopram Oxalate Patent No.IN283492.

Process Patents received for S (+) Dapoxetine Hcl Patent No.IN287150.

Future Plans

Unit-III Greenfield project exclusively for API manufacturing initiated at JN Pharma city Vizag in around 2.3 acres of Area. (Approximate Project cost would be 60 Million Dollars)